PA2H_VIPAP
ID PA2H_VIPAP Reviewed; 138 AA.
AC Q8JFG1; Q6A3P3;
DT 28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT 01-OCT-2002, sequence version 1.
DT 25-MAY-2022, entry version 84.
DE RecName: Full=Acidic phospholipase A2 inhibitor vaspin A chain;
DE Short=svPLA2 homolog;
DE AltName: Full=Vaspin non-toxic component;
DE Flags: Precursor;
OS Vipera aspis aspis (Aspic viper).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC Serpentes; Colubroidea; Viperidae; Viperinae; Vipera.
OX NCBI_TaxID=194601;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC TISSUE=Venom gland;
RX PubMed=12220671; DOI=10.1016/s0014-5793(02)03205-2;
RA Jan V., Maroun R.C., Robbe-Vincent A., De Haro L., Choumet V.;
RT "Toxicity evolution of Vipera aspis aspis venom: identification and
RT molecular modeling of a novel phospholipase A(2) heterodimer neurotoxin.";
RL FEBS Lett. 527:263-268(2002).
RN [2]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC TISSUE=Venom gland;
RX PubMed=17904178; DOI=10.1016/j.toxicon.2007.07.024;
RA Jan V.M., Guillemin I., Robbe-Vincent A., Choumet V.;
RT "Phospholipase A2 diversity and polymorphism in European viper venoms:
RT paradoxical molecular evolution in Viperinae.";
RL Toxicon 50:1140-1161(2007).
CC -!- FUNCTION: Heterodimer: postsynaptic neurotoxin. {ECO:0000250}.
CC -!- FUNCTION: Monomer: the acidic chain inhibits the basic phospholipase A2
CC of the complex. {ECO:0000250}.
CC -!- SUBUNIT: Heterodimer of a toxic basic protein having phospholipase A2
CC activity (B chain (AC Q8JFG0)) and a non-toxic acidic protein
CC functioning as its inhibitor (A chain).
CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}.
CC -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC -!- SIMILARITY: Belongs to the phospholipase A2 family. Group II subfamily.
CC D49 sub-subfamily. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AJ459806; CAD30849.1; -; mRNA.
DR EMBL; AJ580096; CAE47101.1; -; mRNA.
DR EMBL; AJ580097; CAE47102.1; -; mRNA.
DR EMBL; AJ580099; CAE47104.1; -; mRNA.
DR EMBL; AJ580106; CAE47111.1; -; mRNA.
DR AlphaFoldDB; Q8JFG1; -.
DR SMR; Q8JFG1; -.
DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR GO; GO:0004623; F:phospholipase A2 activity; IEA:InterPro.
DR GO; GO:0019834; F:phospholipase A2 inhibitor activity; IEA:UniProtKB-KW.
DR GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR GO; GO:0050482; P:arachidonic acid secretion; IEA:InterPro.
DR GO; GO:0016042; P:lipid catabolic process; IEA:InterPro.
DR GO; GO:0006644; P:phospholipid metabolic process; IEA:InterPro.
DR CDD; cd00125; PLA2c; 1.
DR Gene3D; 1.20.90.10; -; 1.
DR InterPro; IPR001211; PLipase_A2.
DR InterPro; IPR033112; PLipase_A2_Asp_AS.
DR InterPro; IPR016090; PLipase_A2_dom.
DR InterPro; IPR036444; PLipase_A2_dom_sf.
DR PANTHER; PTHR11716; PTHR11716; 1.
DR Pfam; PF00068; Phospholip_A2_1; 1.
DR PRINTS; PR00389; PHPHLIPASEA2.
DR SMART; SM00085; PA2c; 1.
DR SUPFAM; SSF48619; SSF48619; 1.
DR PROSITE; PS00119; PA2_ASP; 1.
PE 2: Evidence at transcript level;
KW Disulfide bond; Neurotoxin; Phospholipase A2 inhibitor;
KW Postsynaptic neurotoxin; Secreted; Signal; Toxin.
FT SIGNAL 1..16
FT /evidence="ECO:0000250"
FT CHAIN 17..138
FT /note="Acidic phospholipase A2 inhibitor vaspin A chain"
FT /id="PRO_0000022969"
FT DISULFID 42..131
FT /evidence="ECO:0000250"
FT DISULFID 44..60
FT /evidence="ECO:0000250"
FT DISULFID 59..111
FT /evidence="ECO:0000250"
FT DISULFID 65..138
FT /evidence="ECO:0000250"
FT DISULFID 66..104
FT /evidence="ECO:0000250"
FT DISULFID 73..97
FT /evidence="ECO:0000250"
FT DISULFID 91..102
FT /evidence="ECO:0000250"
SQ SEQUENCE 138 AA; 15411 MW; 3FD0BF5796FC9FE2 CRC64;
MRTLWIVAVC LIGVEGNLFQ FGDMILQKTG KEAVHSYAIY GCYCGWGGQG RAQDATDRCC
FAQDCCYGRV NDCNPKMATY TYSFENGDIV CGDNDLCLRA VCECDRAAAI CLGENVNTYD
KNYEYYSISH CTEESEQC